Patent · US Active

Method of increasing the bioavailability of silybin

US10265298B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

Macau University of Science and Technology · CN

Inventors

Ying Xie · Macau, CN
Liang Liu · Macau, CN
Hua Zhou · Acton, US

Key dates

Filing date	Aug 22, 2017
Grant date	Apr 23, 2019
Priority date	—
Expiry date	Aug 22, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

One example embodiment relates to a method of increasing bioavailability of silybin in a person. The method includes providing silybin and a flavonoid to the person, wherein the flavonoid is tangeretin or baicalein. Another example embodiment relates to a method of treating chronic liver disease in a person by administering silybin and a flavonoid to the person to treat the chronic liver disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.